Assessing the potentiality of algorithms and artificial intelligence adoption to disrupt patient primary care with a safer and faster medication management: a systematic review protocol.

Journal: BMJ open
Published Date:

Abstract

INTRODUCTION: In primary care, almost 75% of outpatient visits by family doctors and general practitioners involve continuation or initiation of drug therapy. Due to the enormous amount of drugs used by outpatients in unmonitored situations, the potential risk of adverse events due to an error in the use or prescription of drugs is much higher than in a hospital setting. Artificial intelligence (AI) application can help healthcare professionals to take charge of patient safety by improving error detection, patient stratification and drug management. The aim is to investigate the impact of AI algorithms on drug management in primary care settings and to compare AI or algorithms with standard clinical practice to define the medication fields where a technological support could lead to better results.

Authors

  • Antonio Oliva
    Department of Health Surveillance and Bioethics, Section of Legal Medicine, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Gerardo Altamura
    Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Mario Cesare Nurchis
    Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy nurchismario@gmail.com.
  • Massimo Zedda
    Department of Health Surveillance and Bioethics, Section of Legal Medicine, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Giorgio Sessa
    Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Francesca Cazzato
    Department of Health Surveillance and Bioethics, Section of Legal Medicine, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Giovanni Aulino
    Department of Health Surveillance and Bioethics, Section of Legal Medicine, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Martina Sapienza
    Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Maria Teresa Riccardi
    Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Gabriele Della Morte
    Faculty of Law, Università Cattolica del Sacro Cuore, Milan, Italy.
  • Matteo Caputo
    Department of Juridical Science, Section of Criminal Law, Università Cattolica del Sacro Cuore, Milan, Italy.
  • Simone Grassi
    Department of Health Surveillance and Bioethics, Section of Legal Medicine, Fondazione Policlinico A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Gianfranco Damiani